Application of a Novel Multimodal-Based Deep Learning Model for the Prediction of Papillary Thyroid Carcinoma Recurrence

Int J Gen Med. 2024 Dec 31:17:6585-6594. doi: 10.2147/IJGM.S486189. eCollection 2024.

Abstract

Purpose: Papillary thyroid carcinoma (PTC) is the most common thyroid malignancy. Although its mortality rate is low, some patients experience cancer recurrence during follow-up. In this study, we investigated the accuracy of a novel multimodal model by simultaneously analyzing numeric and time-series data to predict recurrence in patients with PTC after thyroidectomy.

Patients and methods: We analyzed patients with thyroid carcinoma who underwent thyroidectomy at the Chungbuk National University Hospital between January 2006 and December 2021. The proposed model used numerical data, including clinical information at the time of surgery, and time-series data, including postoperative thyroid function test results. For the model training with unbalanced data, we employed weighted binary cross-entropy with weights of 0.8 for the positive (recurrence) group and 0.2 for the negative (nonrecurrence) group. We performed four-fold cross-validation of the dataset to evaluate the model performance.

Results: Our dataset comprised 1613 patients who underwent thyroidectomy, including 1550 and 63 patients with nonrecurrent and recurrent PTC, respectively. Patients with recurrence had a larger tumor size, more tumor multiplicity, and a higher male-to-female ratio than those without recurrence. The proposed model achieved an average area under the curve of 0.9622, F1-score of 0.4603, sensitivity of 0.9042, and specificity of 0.9077.

Conclusion: When applying our proposed model, the experimental results showed that it could predict recurrence at least 1 year before occurrence. The multimodal model for predicting PTC recurrence after thyroidectomy showed good performance. In clinical practice, it may help with the early detection of recurrence during the follow-up of patients with PTC after thyroidectomy.

Keywords: follow-up; malignancy; thyroid cancer; thyroidectomy.

Grants and funding

This research was supported by the National IT Industry Promotion Agency (NIPA) grant funded by the Ministry of Science and ICT (MSIT) (grant number: S0252-21-1001, Development of AI Precision Medical Solution [Doctor Answer 2.0]).